These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22179358)

  • 1. Targeting B cells in severe thrombotic thrombocytopenic purpura--a road to cure?
    Kyttaris VC
    Crit Care Med; 2012 Jan; 40(1):317-8. PubMed ID: 22179358
    [No Abstract]   [Full Text] [Related]  

  • 2. Another beneficial effect of rituximab on refractory and relapsing thrombotic thrombocytopenic purpura: the role of interleukin-12 suppression?
    Park SJ; Shin JI
    Crit Care Med; 2012 Apr; 40(4):1391. PubMed ID: 22425862
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
    Froissart A; Buffet M; Veyradier A; Poullin P; Provôt F; Malot S; Schwarzinger M; Galicier L; Vanhille P; Vernant JP; Bordessoule D; Guidet B; Azoulay E; Mariotte E; Rondeau E; Mira JP; Wynckel A; Clabault K; Choukroun G; Presne C; Pourrat J; Hamidou M; Coppo P;
    Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for thrombotic thrombocytopenic purpura.
    Kivity S; Agmon-Levin N
    Isr Med Assoc J; 2011 Jul; 13(7):436-7. PubMed ID: 21838188
    [No Abstract]   [Full Text] [Related]  

  • 5. [Case report; successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura].
    Yoshii Y; Matsumura Y; Boku S; Kamitsuji Y; Yasuda T; Kawase Y; Matsumoto M; Fujimura Y; Uoshima N
    Nihon Naika Gakkai Zasshi; 2013 Jan; 102(1):147-9. PubMed ID: 23777126
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP.
    Bayraktar S; Eileen B; Shariatmadar S; Lian E
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22798444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response to rituximab in two patients with plasma exchange-refractory thrombotic thrombocytopenic purpura].
    Pérez A; Sancho JM; Grífols JR; Ribera JM
    Med Clin (Barc); 2011 Jun; 137(3):139-40. PubMed ID: 21074219
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Narayanan P; Jayaraman A; Rustagi RS; Mahadevan S; Parameswaran S
    Int J Hematol; 2012 Jul; 96(1):122-4. PubMed ID: 22552883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome.
    Caramazza D; Quintini G; Abbene I; Coco LL; Malato A; Di Trapani R; Saccullo G; Pizzo G; Palazzolo R; Barone R; Mazzola G; Rizzo S; Ragonese P; Aridon P; Abbadessa V; Siragusa S
    Blood Transfus; 2010 Jul; 8(3):203-10. PubMed ID: 20671883
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange.
    Basquiera AL; Damonte JC; Abichaín P; Sturich AG; García JJ
    Ann Hematol; 2008 Apr; 87(4):321-3. PubMed ID: 17899079
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of two cases.
    Evans MW; Vaughan LB; Giffi VS; Zimrin AB; Hess JR
    AIDS Patient Care STDS; 2010 Jun; 24(6):349-52. PubMed ID: 20515417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in treating refractory thrombotic thrombocytopenic purpura: three case reports.
    Dalia S; McNulty B; Colvin GA
    Med Health R I; 2008 Jul; 91(7):226-8. PubMed ID: 18705225
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus.
    Limal N; Cacoub P; Sène D; Guichard I; Piette JC
    Lupus; 2008 Jan; 17(1):69-71. PubMed ID: 18089688
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Chow KV; Carroll R; Branley P; Nicholls K; Becker G; Hogan C
    Intern Med J; 2007 May; 37(5):329-32. PubMed ID: 17504282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
    Clark WF; Rock G; Barth D; Arnold DM; Webert KE; Yenson PR; Kelton JG; Li L; Foley SR;
    Br J Haematol; 2015 Jul; 170(2):208-17. PubMed ID: 25855259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports.
    Iioka F; Shimomura D; Ishii T; Maesako Y; Ohgoe K; Nakamura F; Matsuo S; Ohno H
    Int J Hematol; 2012 Oct; 96(4):506-12. PubMed ID: 22878941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.
    Ozdogu H; Boga C; Kizilkilic E; Yeral M; Kozanoglu I; Karatas M
    J Thromb Thrombolysis; 2007 Apr; 23(2):147-50. PubMed ID: 17221322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in the treatment of TTP.
    Scully M
    Hematology; 2012 Apr; 17 Suppl 1():S22-4. PubMed ID: 22507771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura.
    George JN
    Am J Hematol; 2012 May; 87 Suppl 1():S88-91. PubMed ID: 22407740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.
    Scully M; McDonald V; Cavenagh J; Hunt BJ; Longair I; Cohen H; Machin SJ
    Blood; 2011 Aug; 118(7):1746-53. PubMed ID: 21636861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.